Keywords:
Abrysvo®; Beyfortus®; Infant; Maternal vaccine; Nirsevimab; RSV; RSVpreF; Respiratory syncytial virus; Risk factors
Abstract:
Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory infections globally in children under five years. With the development of RSV prevention strategies, understanding risk factors and relation to age and population is useful for deciding the type of program implemented.